ClinicalTrials.Veeva

Menu

Does Neuromuscular Electrical Stimulation Benefit the Functional Ability of Elderly Patients With Chronic Obstructive Lung Disease (NEMS for COPD)

B

Beni-Suef University

Status

Completed

Conditions

Neuromuscular Electrical Stimulation
Chronic Obstructive Lung Disease
Pulmonary Function (FEV1/FVC)
Pulmonary Rehabilitation

Treatments

Other: Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES)
Other: Control Group Chest physical therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05838911
BeniSuefU_1

Details and patient eligibility

About

Background: Patients with COPD often experience skeletal muscle dysfunction. For those who are unable or unwilling to undertake physical training, neuromuscular electrical stimulation (NMES) may provide an alternative method of exercise training.

Objective: To investigate the effects of adding neuromuscular electrical stimulation of gluteus maximus, quadriceps and calf muscles to chest physiotherapy, compared to chest physiotherapy alone, on muscles strength (gluteus max., quadriceps, calf muscles), femoral blood flow physical and pulmonary function in severe COPD Patients.

Full description

Material and methods: This study include a group of 60 patients (30 males and 30 females) diagnosed with severe COPD), their age is ranged 65-75 years, they will be randomly divided into two groups; study group (A) 30 patients and study group (B) 30 patients. Study group (A): The patients in this group will receive the chest physiotherapy program for 20 min each day, for five days a week for three consecutive weeks. Study group (B): The patients in this group will receive the same chest physiotherapy program combined with neuromuscular electrical stimulation of gluteus max., quadriceps, calf muscles, performed for 30 min /day for five days a week for three consecutive weeks. Femoral blood Flow, gluteus maximus, quadriceps and calf muscles strength and pulmonary function (FEV1/FVC) will be measured for both groups pre and post treatment.

Enrollment

60 patients

Sex

All

Ages

65 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A diagnosis of COPD with FEV1/FVC <50% predicted as per the GOLD guidelines.
  • Self-reported dyspnea and/or arm fatigue during at least one activity of daily living that required arm exercise.
  • Dyspnea and/or physical activity fatigue were self-reported by the Borg Scale.
  • Before entering in the study, all patients had their pulmonary function optimized with long-acting bronchodilators and corticosteroids.

Exclusion criteria

  • • Patients with unstable angina pectoris.

    • Progressive ventricular dysrhythmia.
    • Intermittent claudication.
    • Implanted cardiac pacemakers.
    • Uncontrolled diabetes mellitus.
    • Peripheral vascular disease.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Control Group
Active Comparator group
Description:
The patients in this group were received the chest physiotherapy program for 20 min each day, for five days a week for three consecutive weeks.
Treatment:
Other: Control Group Chest physical therapy
Study Group
Experimental group
Description:
The patients in this group were received the same chest physiotherapy program combined with neuromuscular electrical stimulation (NMES) of gluteus max., quadriceps, and calf muscles performed for 30 min /day for five days a week for three consecutive weeks.
Treatment:
Other: Study Group chest physiotherapy program combined with neuromuscular electrical stimulation (NMES)

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed S. A. youssef, PhD; Ahmed S. A. youssef

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems